148 related articles for article (PubMed ID: 4846373)
1. [Various immunological aspects of demyelinations. II. Attempts at the determination of immunological reactions in multiple sclerosis].
Vymazal J; Krásenská-Dlabacová J
Cesk Neurol Neurochir; 1974 Jul; 37(4):240-6. PubMed ID: 4846373
[No Abstract] [Full Text] [Related]
2. [Multiple sclerosis].
Igata A
Nihon Rinsho; 1970 Jul; 28(7):1886-91. PubMed ID: 4918043
[No Abstract] [Full Text] [Related]
3. [Immunological treatments in multiple sclerosis].
Abramsky O
Harefuah; 1981 Aug; 101(3-4):73-4. PubMed ID: 7319393
[No Abstract] [Full Text] [Related]
4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive treatment im multiple sclerosis].
Mertin J
Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
[TBL] [Abstract][Full Text] [Related]
6. [Current data on the etiopathogenesis of multiple sclerosis].
Duca E
Neurol Psihiatr Neurochir; 1972; 17(5):385-94. PubMed ID: 4632587
[No Abstract] [Full Text] [Related]
7. New treatments for multiple sclerosis.
Hallpike JF
Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
[No Abstract] [Full Text] [Related]
8. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
Meyer-Rienecker H; Hitzschke B
Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
[No Abstract] [Full Text] [Related]
9. [Treatment of multiple sclerosis (recent concepts)].
Marteau R
Rev Med Liege; 1972 Aug; 27(16):543-6. PubMed ID: 5052716
[No Abstract] [Full Text] [Related]
10. [Review of the therapy of multiple sclerosis].
De Rosa A; Puccini A; De Martino V
Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
[No Abstract] [Full Text] [Related]
11. [Immunosuppressive treatment of multiple sclerosis].
Frick E
Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
[No Abstract] [Full Text] [Related]
12. [Immunological aspects of multiple sclerosis. II. Characterization of antilymphocyte antibodies].
Scheimberg MA; Tilbery CP
Rev Paul Med; 1987; 105(3):143-5. PubMed ID: 3502427
[No Abstract] [Full Text] [Related]
13. [Clinical picture and therapy of multiple sclerosis].
Schrader A
Wien Med Wochenschr; 1972 Mar; 122(10):129-34. PubMed ID: 4334261
[No Abstract] [Full Text] [Related]
14. [Immunological aspects of multiple sclerosis].
Bakouche P
Munch Med Wochenschr; 1969 Sep; 111(39):1985-7. PubMed ID: 4309930
[No Abstract] [Full Text] [Related]
15. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
Tourbah A; Fontaine B; Lyon-Caen O
Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
[TBL] [Abstract][Full Text] [Related]
16. [Immunological aspects in multiple sclerosis. I. Lymphocyte subpopulations and antilymphocyte antibodies].
Tilbery CP; Lima JG; Scheimberg MA
Rev Paul Med; 1987; 105(3):134-40. PubMed ID: 3502426
[No Abstract] [Full Text] [Related]
17. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
Cendrowski W
Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
[No Abstract] [Full Text] [Related]
18. [Various immunological aspects of demyelinations. I. Information on the mechanisms of induction and inhibition of experimental allergic encephalitis].
Vymazal J; Krásenská-Dlabacová J
Cesk Neurol Neurochir; 1974 Jul; 37(4):235-9. PubMed ID: 4846372
[No Abstract] [Full Text] [Related]
19. [Specific immunosuppressive therapy (antilymphocytic serums)].
Mazzei D
Resen Clin Cient; 1969; 38(7):183-8. PubMed ID: 5398775
[No Abstract] [Full Text] [Related]
20. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
Svenningsson A; Andersson M; Olsson T
Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
